Cochrane Evidence Synthesis and Methods ►

Contrast-enhanced ultrasound compared with computed tomography, magnetic resonance imaging, and positron emission tomography-computed tomography for diagnosing liver metastases in people with newly diagnosed colorectal cancer

This is a protocol for a Cochrane Review (diagnostic). The objectives are as follows:

To determine the diagnostic accuracy of contrast-enhanced ultrasound (CEUS) versus contrast-enhanced computed tomography (CECT), magnetic resonance imaging (MRI), and fluro-18-deoxyglucose positron emission tomography-computed tomography (18F-FDG PET/CT) for diagnosing liver metastases in people with newly diagnosed colorectal cancer.

This is a protocol.

Health topics:

Cancer > Colorectal > Early detection

Gastroenterology & hepatology > Liver disorders > Liver surgery

Cancer > Liver

Diagnosis > Diagnostic test accuracy

Published:

17 May 2020

Authors:

Lund M, Nadarevic T, Bjerre TAbramovitz, Grønbæk H, Mortensen F, Kragh Andersen P

See the full Review on

the Cochrane Library

►

Was this helpful? Donate.

If you found this evidence helpful, please consider donating to Cochrane. We are a charity that produces accessible evidence to help people make health and care decisions.
Donate
Print
PDF
Citation
Lund M, Nadarevic T, Bjerre TAbramovitz, Grønbæk H, Mortensen F, Kragh Andersen P. Contrast-enhanced ultrasound compared with computed tomography, magnetic resonance imaging, and positron emission tomography-computed tomography for diagnosing liver metastases in people with newly diagnosed colorectal cancer (Protocol). Cochrane Database of Systematic Reviews 2020, Issue 5. Art. No.: CD012388. DOI: 10.1002/14651858.CD012388.pub2.